Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)
Saudi Arabia · Delayed Price · Currency is SAR 30.22
-0.46 (-1.50%)
Jul 23, 2026, 3:19 PM AST
TADAWUL:2070 Financials Overview
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,646 | 1,707 | 1,682 | 1,655 | 1,422 | 1,460 |
Revenue Growth | -2.67% | 1.47% | 1.60% | 16.43% | -2.60% | -6.14% |
Gross Profit Gross Profit Growth | 827.87 | 820.65 | 816.05 | 689.64 | 557.31 | 613.05 |
Operating Income Operating Income Growth | 253.04 | 226.6 | 116.02 | 59.72 | -108.08 | 32.83 |
Net Income Net Income Growth | 178.61 | 184.36 | 24.54 | -50.73 | -165.14 | 26.45 |
Earnings Per Share EPS Growth | 1.50 | 1.54 | 0.21 | -0.42 | -1.38 | 0.22 |
EPS Growth | 197.91% | 652.54% | - | - | - | -78.80% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Healthcare Services Healthcare Services Growth | 177.45 | 178.77 | 162.66 | 161.39 | 129.31 | 103.88 |
Trading & Distribution Services Trading & Distribution Services Growth | 72.97 | 83.66 | 122.22 | 197.33 | 899.76 | - |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 1,395 | 1,444 | 1,397 | 1,297 | 392.74 | - |
Total Total Growth | 1,646 | 1,707 | 1,682 | 1,655 | 1,427 | 1,460 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 341.6 | 384.38 | 277.62 | 276.03 | 380.77 | 895.99 |
Total Debt Total Debt Growth | 1,273 | 1,434 | 1,513 | 1,119 | 1,082 | 1,295 |
Net Cash (Debt) Net Cash Growth | -931.72 | -1,050 | -1,235 | -843.22 | -700.97 | -398.82 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -7.81 | -8.80 | -10.33 | -7.05 | -5.84 | -3.32 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 365.28 | 272.35 | -330.96 | 10.87 | -99.3 | 86.71 |
Capital Expenditures CapEx Growth | -82.3 | -89.14 | -71.27 | -106.79 | -78.21 | -76.24 |
Free Cash Flow Free Cash Flow Growth | 282.98 | 183.21 | -402.23 | -95.92 | -177.51 | 10.47 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 50.30% | 48.08% | 48.52% | 41.66% | 39.20% | 42.00% |
Operating Margin | 15.38% | 13.28% | 6.90% | 3.61% | -7.60% | 2.25% |
Pretax Margin | 12.94% | 12.05% | 4.28% | 0.31% | -9.33% | 2.31% |
Profit Margin | 10.85% | 10.80% | 1.46% | -3.06% | -11.61% | 1.81% |
FCF Margin | 17.20% | 10.73% | -23.91% | -5.79% | -12.48% | 0.72% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.350 | 0.350 | - | - | - | 0.600 |
Dividend Per Share Growth | 0% | - | - | - | - | -40.00% |
Dividend Yield | 1.16% | 1.36% | - | - | - | 1.57% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.19 | 16.87 | 156.27 | - | - | 178.50 |
Forward PE | 15.70 | 16.16 | 29.44 | 54.19 | 62.57 | 25.66 |
P/FCF Ratio | 12.75 | 16.98 | - | - | - | 451.01 |
PS Ratio | 2.19 | 1.82 | 2.28 | 2.74 | 1.84 | 3.24 |